Balance Risks and Benefits of Antithrombotic Combos in Atrial Fib
Antithrombotic combos for patients with atrial fib PLUS a coronary stent are a moving target...due to evolving evidence and stent technology.
The standard used to be "triple therapy"...an anticoagulant (warfarin, etc) plus TWO antiplatelets (aspirin and clopidogrel, etc).
But these combos are a tightrope walk...and risk of bleeding must be balanced against risk of embolic stroke, MI, or stent thrombosis.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote